Mangoceuticals to Merge with Nuclea to Advance Morpheus Microreactor to Market
Mangoceuticals announced on July 30 that it has signed a definitive business combination agreement with advanced nuclear technology company Nuclea Energy Inc., aiming to bring the latter's Morpheus microreactor to the public capital markets. Nuclea was founded in August 2023 and is headquartered in Mississauga, Ontario, Canada, focusing on the development of lead-cooled, factory-fabricated micro-modular reactors. Under the agreement, a newly formed subsidiary of Mangoceuticals will merge with Nuclea, and the combined company will operate as an indirect wholly owned subsidiary of Mangoceuticals. Upon completion of the transaction, holders of Nuclea common shares will receive...
2026-07-31
